Evidence map›Paper›PMID 34038413›Full record

ArticlePLoS medicine2021

Evaluation of splenic accumulation and colocalization of immature reticulocytes and Plasmodium vivax in asymptomatic malaria: A prospective human splenectomy study.

Steven Kho, Labibah Qotrunnada, Leo Leonardo, Benediktus Andries, Putu A I Wardani, Aurelie Fricot, Benoit Henry, David Hardy, Nur I Margyaningsih, Dwi Apriyanti and 22 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
18.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 113 citations in OpenAlex.

  1. Comparable severity ofNew microbes and new infections · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Malaria.The New England journal of medicine · 2025
    Review
  18. Review
  19. Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors at 14 institutions in 8 countries.

Steven KhoGlobal and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia.
Labibah QotrunnadaEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Leo LeonardoTimika Malaria Research Program, Papuan Health and Community Development Foundation, Timika, Papua, Indonesia.
Benediktus AndriesTimika Malaria Research Program, Papuan Health and Community Development Foundation, Timika, Papua, Indonesia.ORCID 0000-0002-0354-456X
Putu A I WardaniRumah Sakit Umum Daerah Kabupaten Mimika, Timika, Papua, Indonesia.
Aurelie FricotUMR_S1134, BIGR, Inserm, Université de F-75015 Paris, and Laboratory of Excellence GR-Ex, Paris, France.
Benoit HenryUMR_S1134, BIGR, Inserm, Université de F-75015 Paris, and Laboratory of Excellence GR-Ex, Paris, France.ORCID 0000-0003-4916-4121
David HardyInstitut Pasteur, Experimental Neuropathology Unit, Paris, France.ORCID 0000-0001-5874-4377
Nur I MargyaningsihEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Dwi ApriyantiEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Agatha M PuspitasariEijkman Institute for Molecular Biology, Jakarta, Indonesia.ORCID 0000-0003-4191-5023
Pak PrayogaTimika Malaria Research Program, Papuan Health and Community Development Foundation, Timika, Papua, Indonesia.
Leily TriantyEijkman Institute for Molecular Biology, Jakarta, Indonesia.ORCID 0000-0002-4368-476X
Enny KenangalemTimika Malaria Research Program, Papuan Health and Community Development Foundation, Timika, Papua, Indonesia.
Fabrice ChretienInstitut Pasteur, Experimental Neuropathology Unit, Paris, France.
Valentine BrousseUMR_S1134, BIGR, Inserm, Université de F-75015 Paris, and Laboratory of Excellence GR-Ex, Paris, France.
Innocent SafeukuiDepartment of Biological Sciences, Notre Dame University, Notre Dame, Indiana, United States of America.
Hernando A Del PortilloISGlobal, Hospital Clinic-Universitat de Barcelona, Barcelona, Spain.ORCID 0000-0002-5278-3452
Carmen Fernandez-BecerraISGlobal, Hospital Clinic-Universitat de Barcelona, Barcelona, Spain.
Elamaran MeibalanDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America.ORCID 0000-0002-3832-8955
Matthias MartiDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America.ORCID 0000-0003-1040-9566
Ric N PriceGlobal and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia.ORCID 0000-0003-2000-2874
Tonia WoodberryGlobal and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia.
Papa A NdourUMR_S1134, BIGR, Inserm, Université de F-75015 Paris, and Laboratory of Excellence GR-Ex, Paris, France.ORCID 0000-0001-7203-9754
Bruce M RussellDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.ORCID 0000-0003-2333-4348
Tsin W YeoGlobal and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia.ORCID 0000-0002-4060-7902
Gabriela MinigoGlobal and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia.
Rintis NoviyantiEijkman Institute for Molecular Biology, Jakarta, Indonesia.ORCID 0000-0003-1383-3274
Jeanne R PoespoprodjoTimika Malaria Research Program, Papuan Health and Community Development Foundation, Timika, Papua, Indonesia.ORCID 0000-0003-1573-734X
Nurjati C SiregarEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Pierre A BuffetUMR_S1134, BIGR, Inserm, Université de F-75015 Paris, and Laboratory of Excellence GR-Ex, Paris, France.ORCID 0000-0003-4010-929X
Nicholas M AnsteyGlobal and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia.ORCID 0000-0002-2192-0506
Eijkman Institute for Molecular Biology · IDCharles Darwin University · AUInserm · FRState University of Papua · IDInstitut Pasteur · FRBrigham and Women's Hospital · USHarvard University · USInstitució Catalana de Recerca i Estudis Avançats · ESInstitut d'Investigació en Ciències de la Salut Germans Trias i Pujol · ESMahidol University · THRumah Sakit Umum Daerah Kabupaten MimikaUniversitas Gadjah Mada · IDUniversity of Notre Dame · USUniversity of Otago · NZ

Funding

Wellcome Trust 099875Wellcome Trust 200909Wellcome Trust 200909/Z/16/Z
6 · The paper itself

Abstract

backgroundA very large biomass of intact asexual-stage malaria parasites accumulates in the spleen of asymptomatic human individuals infected with Plasmodium vivax. The mechanisms underlying this intense tropism are not clear. We hypothesised that immature reticulocytes, in which P. vivax develops, may display high densities in the spleen, thereby providing a niche for parasite survival. METHODS AND

findingsWe examined spleen tissue in 22 mostly untreated individuals naturally exposed to P. vivax and Plasmodium falciparum undergoing splenectomy for any clinical indication in malaria-endemic Papua, Indonesia (2015 to 2017). Infection, parasite and immature reticulocyte density, and splenic distribution were analysed by optical microscopy, flow cytometry, and molecular assays. Nine non-endemic control spleens from individuals undergoing spleno-pancreatectomy in France (2017 to 2020) were also examined for reticulocyte densities. There were no exclusion criteria or sample size considerations in both patient cohorts for this demanding approach. In Indonesia, 95.5% (21/22) of splenectomy patients had asymptomatic splenic Plasmodium infection (7 P. vivax, 13 P. falciparum, and 1 mixed infection). Significant splenic accumulation of immature CD71 intermediate- and high-expressing reticulocytes was seen, with concentrations 11 times greater than in peripheral blood. Accordingly, in France, reticulocyte concentrations in the splenic effluent were higher than in peripheral blood. Greater rigidity of reticulocytes in splenic than in peripheral blood, and their higher densities in splenic cords both suggest a mechanical retention process. Asexual-stage P. vivax-infected erythrocytes of all developmental stages accumulated in the spleen, with non-phagocytosed parasite densities 3,590 times (IQR: 2,600 to 4,130) higher than in circulating blood, and median total splenic parasite loads 81 (IQR: 14 to 205) times greater, accounting for 98.7% (IQR: 95.1% to 98.9%) of the estimated total-body P. vivax biomass. More reticulocytes were in contact with sinus lumen endothelial cells in P. vivax- than in P. falciparum-infected spleens. Histological analyses revealed 96% of P. vivax rings/trophozoites and 46% of schizonts colocalised with 92% of immature reticulocytes in the cords and sinus lumens of the red pulp. Larger splenic cohort studies and similar investigations in untreated symptomatic malaria are warranted.

conclusionsImmature CD71+ reticulocytes and splenic P. vivax-infected erythrocytes of all asexual stages accumulate in the same splenic compartments, suggesting the existence of a cryptic endosplenic lifecycle in chronic P. vivax infection. Findings provide insight into P. vivax-specific adaptions that have evolved to maximise survival and replication in the spleen.

Indexed as

AdolescentAdultAsymptomatic InfectionsFemaleHumansIndonesiaMalaria, VivaxMaleMiddle AgedNew GuineaPlasmodium vivaxProspective StudiesReticulocytesSpleenSplenectomyYoung Adult

Identifiers

PMID34038413
PMCPMC8154101
OpenAlexW3165592103

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.